[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341577-105":59,"doc-detail-341577-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","functional-characterization-of-the-human-brca1-11-splicing-isoforms-in-yeast-abstract","Functional Characterization of the Human BRCA1 - ∆11 Splicing Isoforms in Yeast - Abstract","","BRCA1 is a crucial tumor suppressor gene whose multiple splicing isoforms, including ∆9–11, ∆11, and ∆11q, lack exon 11 and therefore encode major protein portions. These isoforms occur in both normal and cancer cells with altered activity versus full-length BRCA1. The cancer-risk impact of germline intronic variants that drive exclusive ∆11 isoform expression remains uncertain and is treated as VUS, challenging conventional classification. A yeast-based functional assay is used to compare ∆11 isoforms with known pathogenic missense variants, clarifying functional consequences and potential contributions to cancer risk.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/functional-characterization-of-the-human-brca1-11-splicing-isoforms-in-yeast-abstract/341577/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/functional-characterization-of-the-human-brca1-11-splicing-isoforms-in-yeast-abstract/341577.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are BRCA1 ∆11 splicing isoforms classified as variants of uncertain significance (VUS)?","Question",{"text":112,"@type":113},"Because germline intronic variants that promote exclusive ∆11 isoform expression have uncertain impacts on cancer risk, making their classification challenging with traditional genetic methods.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What assay is used to compare the BRCA1 ∆11 isoforms with known pathogenic variants?",{"text":117,"@type":113},"A yeast-based functional assay, previously validated for missense BRCA1 variants, is used to assess and compare the activity of ∆11 splicing isoforms against known pathogenic missense variants.",{"name":119,"@type":110,"acceptedAnswer":120},"How does missing exon 11 affect BRCA1 isoforms’ function?",{"text":121,"@type":113},"The ∆11-related isoforms lack exon 11 sequences, which removes large portions of the protein encoded by exon 11, leading to altered activity compared with full-length BRCA1.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341577,1790304243,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Communication  \nFunctional Characterization of the Human BRCA1 ∆11 Splicing Isoforms in Yeast  \nAlvaro Galli 1,†, Francesca Bellè 1,†, Arcangelo Fargnoli 1, Maria Adelaide Caligo 2 and Tiziana Cervelli 1, *  \nCitation: Galli, A.; Bellè, F.; Fargnoli, A.; Caligo, M.A.; Cervelli, T. Functional Characterization of the Human BRCA1 ∆11 Splicing Isoforms in Yeast. Int. J. Mol. Sci. 2024, 25, 7511 . [https://doi.org/10.3390/ijms25147511](https://doi.org/10.3390/ijms25147511)  \nAcademic Editor: Naoyuki Kataoka  \nReceived: 15 June 2024  \nRevised: 4 July 2024  \nAccepted: 5 July 2024  \nPublished: 9 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Yeast Genetics and Genomics, Laboratory of Functional Genetics and Genomics, Institute of Clinical  \nPhysiology, National Research Council, 56124 Pisa, Italy; [alvaro.galli@cnr.it](alvaro.galli@cnr.it) (A.G.); [f.belle01@gmail.com](f.belle01@gmail.com) (F.B.); [arcangelo.fargnoli@hotmail.it](arcangelo.fargnoli@hotmail.it) (A.F.)  \n2 Molecular Genetics Unit, Department of Oncology, University Hospital of Pisa, 56126 Pisa, Italy; [m.caligo@ao-pisa.toscana.it](m.caligo@ao-pisa.toscana.it)  \n* Correspondence: [tiziana.cervelli@cnr.it](tiziana.cervelli@cnr.it)[ ](tiziana.cervelli@cnr.it)† These authors contributed equally to this work.  \nAbstract: BRCA1, a crucial tumor suppressor gene, has several splicing isoforms, including ∆9–11,∆11, and ∆11q, which lack exon 11, coding for significant portions of the protein. These isoforms are naturally present in both normal and cancerous cells, exhibiting altered activity compared to the full-length BRCA1 . Despite this, the impact on cancer risk of the germline intronic variants promoting the exclusive expression of these ∆11 isoforms remains uncertain. Consequently, they are classified as variants of uncertain significance (VUS), posing challenges for traditional genetic classification methods due to their rarity and complexity. Our research utilizes a yeast-based functional assay, previously validated for assessing missense BRCA1 variants, to compare the activity of the ∆11 splicing isoforms with known pathogenic missense variants. This approach allows us to elucidate the functional implications of these isoforms and determine whether their exclusive expression could contribute to increased cancer risk. By doing so, we aim to provide insights into the pathogenic potential of intronic VUS-generating BRCA1 splicing isoforms and improve the classification of BRCA1 variants.  \nKeywords: BRCA1 ∆11 splicing isoforms; yeast-based functional assay; BRCA1 intronic variants; BRCA1 localization  \n1. Introduction  \nGermline mutations of the DNA repair gene BRCA1 have been reported to increase the lifetime risk of hereditary breast and ovarian cancer (HBOC) [1,2] . The full-length BRCA1 protein (FL) is composed of 1863 amino acids forming a 220 kDa protein characterized by three well-conserved functional domains: the RING domain (exons 2–7), a region encoded by exons 11–13, and the BRCT domain (exons 16–24) . The RING domain functions as an E3 ubiquitin ligase. The BRCT domain is a phosphoprotein-binding domain with specificity for proteins phosphorylated by ATM/ATR kinases. Exon 11 is one of the biggest human exons, spanning 3426 bases and encoding for more than 60% of the total protein (1142 aa) [3] . It contains two nuclear localization signals (NLSs) and the protein-binding domains for proteins involved in DNA damage repair (Figure 1A) [4] . Interestingly, it has been proposed as a “coldspot”, namely a region that can tolerate variations because missense variants localized in this exon are classified as benign [5] . However, many missense variant","cbCaiopeB4MW3cQC","https://ap.wps.com/l/cbCaiopeB4MW3cQC","pdf",3532869,12,"English","# Introduction\n## BRCA1 structure and exon 11 properties\n# Materials and Methods\n## Yeast-based functional assay design (substrates, readouts, controls)\n# Results\n## Expression and activity of BRCA1 ∆11 isoforms\n# Discussion\n## Implications for classifying intronic VUS and cancer risk","[{\"question\":\"Why are BRCA1 ∆11 splicing isoforms classified as variants of uncertain significance (VUS)?\",\"answer\":\"Because germline intronic variants that promote exclusive ∆11 isoform expression have uncertain impacts on cancer risk, making their classification challenging with traditional genetic methods.\"},{\"question\":\"What assay is used to compare the BRCA1 ∆11 isoforms with known pathogenic variants?\",\"answer\":\"A yeast-based functional assay, previously validated for missense BRCA1 variants, is used to assess and compare the activity of ∆11 splicing isoforms against known pathogenic missense variants.\"},{\"question\":\"How does missing exon 11 affect BRCA1 isoforms’ function?\",\"answer\":\"The ∆11-related isoforms lack exon 11 sequences, which removes large portions of the protein encoded by exon 11, leading to altered activity compared with full-length BRCA1.\"}]","Functional Characterization of the Human BRCA1 - ∆11 Splicing Isoforms in Yeast - Abstract | PDF",1790042648,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b019fffe039686d076d5ab0c864ac31b.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41fa389a1922d9fc2afff9cd91f407d8.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/340ad8ee017fcc56aaa754c9e812a73f.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7179f81832b276bdd034b4a1637233c2.webp",980,1385]